14.03.2022 14:00:00

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates NEOG, RCM, BRG, OCDX, APR

NEW YORK, March 14, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

logo (PRNewsfoto/Halper Sadeh LLP)

NEOGEN Corporation (NASDAQ: NEOG)'s merger with 3M's Food Safety business. Under the merger, NEOGEN will issue shares to 3M shareholders such that existing NEOGEN shareholders will own approximately 49.9% of the combined company. 3M will also receive consideration valued at approximately $1 billion, subject to closing and other adjustments. If you are a NEOGEN shareholder, click here to learn more about your rights and options.

R1 RCM Inc. (NASDAQ: RCM)'s merger with Cloudmed. Upon closing of the merger, R1 shareholders are expected to own approximately 70% of the combined company on a fully diluted basis while Cloudmed equity holders are expected to own approximately 30%. If you are a RCM shareholder, click here to learn more about your rights and options.

Bluerock Residential Growth REIT, Inc. (NYSE: BRG)'s sale to affiliates of Blackstone Real Estate for $24.25 per share. If you are a Bluerock shareholder, click here to learn more about your rights and options.

Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)'s sale to Quidel Corporation. Under the terms of the proposed agreement, Ortho shareholders will receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined company for each Ortho common share, with Ortho shareholders expected to own approximately 38% of the combined company. with Ortho Clinical Diagnostics Holdings plc. If you are an Ortho shareholder, click here to learn more about your rights and options.  

Apria, Inc. (NASDAQ: APR)'s sale to Owens & Minor, Inc. for $37.50 per share in cash. If you are an Apria shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-notice-halper-sadeh-llp-investigates-neog-rcm-brg-ocdx-apr-301501561.html

SOURCE Halper Sadeh LLP

Nachrichten zu Ortho Clinical Diagnostics Holdings PLC Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Ortho Clinical Diagnostics Holdings PLC Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Neogen Corp. 13,10 -2,24% Neogen Corp.